Search Weight Loss Topics:

Page 41«..1020..40414243..5060..»

Home » Testosterone » Page 41

Testosterone is what separates the men from the boys literally. This sex hormone is naturally produced by the body and plays a big role in the development of male characteristics, although, women produce it too, just in smaller amounts (well talk more about testosterone in a minute). And low testosterone, especially in men, is associated with chronic health issues and even premature death. (1)

Now youre probably wondering what are 8 foods that kill testosterone (since that is the title of this article). But we want to make one thing clear, there likely isnt a single food that will kill testosterone levels. However, its a no-brainer that a low-quality diet will affect health, and therefore lower test levels.

Although, there are some foods that may not be the worst, but that studies have shown to be associated with lower testosterone levels.

So, weve provided those studies below, but take them with a grain of salt regarding the extent to which they show certain foods to negatively affect test levels. Moderation is usually key as with a lot of things and we realize that. We also suggest getting your test levels checked if you suspect that you have low levels, then possibly change/improve your diet if you believe your nutritional habits may not be as healthy and balanced as it could be.

Alright, lets get into these 8 foods that kill testosterone (potentially).

Theres no debate here. Delectable treats, sugar drinks, junk foods, fast foods, highly-processed low-quality meats, and anything in between tend to make up a concerning portion of the typical American diet.

These foods are loaded with calories, simple sugars, saturated fat, sodium, and low-quality protein that, when consumed in excessive amounts over a prolonged period, are not conducive to good health.

Its well known that consuming a lot of refined carbohydrates and saturated fats is associated with obesity, Type 2 diabetes/reduced insulin sensitivity, high cholesterol/blood pressure, and other common health concerns. But having chronic health issues tends to throw the body out of homeostasis and so its easy to see how testosterone levels are affected.

In fact, one scientific review from 2018 found that individuals who prefer Western-style foods and eat out a lot are more likely to have more visceral fat, less muscle mass, low serum total T levels, and a higher chance of developing hypogonadism (lack of testosterone production) (2).

While its not necessarily a sin to have dessert, pizza, ice cream, and all of the mouth-watering options that have become a part of our daily or weekly diet, these foods are likely to contribute to lower test and over time, bad health.

Related: 5 High-Carb Foods To Avoid And Their Healthy Alternatives and Carb Cycling Calculator

Who doesnt like to enjoy an alcoholic beverage every now and then? Well, its likely not an issue unless youre consuming it on a regular basis. And actually, moderate wine consumption, more specifically red wine, can be beneficial for your health. Research has shown that wine can provide disease-fighting antioxidants (polyphenols) that can reduce oxidative stress and inflammation, causes of death.

But it can even widen blood vessels, therefore, improving high blood pressure, cholesterol (also increases HDL cholesterol), and preventing heart disease. Plus, it has shown to have beneficial properties for supporting health overall (3, 4).

However, too much alcohol is a bad thing and one of the top causes of mortality in the world. Overconsumption over a prolonged period can negatively overall health that will consequently affect hormone levels.

According to health.gov, women can safely have up to one drink per day while men can safely have up to two drinks per day. But it really depends on the type of alcoholic beverage since they do vary in alcohol content. So, youll want to check health.gov or any authority link to determine an appropriate amount for you (5).

Now as far as alcohols effects on testosterone, research is mixed. So much so in fact, that according to one study, acute alcoholic intoxication was shown to increase testosterone in women, and decrease levels in men. And this seems to be the case in other studies as well, implying that gender and sexual maturity could be a factor (6, 7).

But more studies need to be carried out to better investigate the relationship between varying alcoholic doses and lowered testosterone levels.

While studies in humans are limited, the possibility of soy lowering testosterone levels has always been a concern.

Common soy food products include soy, tempeh, soy milk, soy protein drinks. These foods are known to contain phytoestrogens that have been associated with having estrogenic effects in the body, therefore causing reduced testosterone levels in men especially (8).

In one study of thirty-five men, individuals who consumed both low and high-isoflavone soy isolate protein for 57 days experienced decreased DHT and DHT/testosterone with minor effects on other hormones (9).

However, in contrast, one review of studies determined no negative effects on testosterone levels in men (10).

Therefore, more studies are needed for conclusive evidence on the potential effects of soy on testosterone levels. But its important to note that some research has suggested that soy could potentially have less than desirable effects in the body without altering hormones and that theyll go away when you stop consuming it.

If you suspect that soy is having certain effects on your body, you might want to switch to something else or get medical advice.

But if its working for you, theres no need to stop eating soy, especially since it has a big role in the typical vegan diet.

Not all foods with the name vegetable are good for you apparently. Vegetable oils such as canola, peanut, corn, and soybean could contribute to lower testosterone. But its important to note that these oils contain polyunsaturated fats that are liquid at room temperature unlike saturated fats, and are typically deemed good for heart, brain, and other improvements in health (11).

However, like several of the options on our list of foods that kill testosterone (potentially), healthy doesnt necessarily mean a certain food wont mess with testosterone levels.

In some studies, consuming polyunsaturated fats on a frequent basis resulted in decreased testosterone levels. Although, more studies are needed to come to a better conclusion on the potentially negative effects of polyunsaturated fats where it relates to T levels due to relatively smaller sample sizes tested (12, 13).

We should also mention that because oil is high-calorie by nature, consuming too much of it could contribute to weight/fat gain that compromises fat in itself. Moderation is key once again.

Nuts also contain polyunsaturated fats like vegetable oils, and although several varieties contain beneficial nutrients, consuming certain nuts in higher amounts can increase levels of sex hormone-binding globulin (SHBG), a protein that binds to testosterone. That may sound like a good thing but SHBG is linked to lower free testosterone levels (14).

Almonds and walnuts may be culprits but there needs to be more research to learn which nuts may have the most negative effects on testosterone levels.

Flaxseed is a nutritional food that provides good fats (Omega-3s), fiber, that supports good digestion, and nutrients to support overall good health. Not to mention, it contains lignans that may help to reduce cancer and other health factors (15, 16, 17).

But you know the drill it has been associated with a decrease in testosterone levels.

And actually, both lignans and Omega-3 fatty acids contained in flaxseed may cause a reduction in T levels. Lignans cause testosterone excretion after binding to it in the body and in a study of 78 women with PCOS (Polycystic Ovarian Syndrome), who took 3g/d Omega-3s for eight weeks,testosterone concentration was significantly lower. (18, 19).

Theres also a study where men with prostate cancer experienced a significant reduction in serum and total testosterone levels after taking 30g/day of flaxseed and eating a lower-fat diet (20).

There are a few other studies that saw similar results.

Read: Healthy Fats The 7 Functional Fatty Foods You Can Eat For Fat Loss

Mint? Were not saying you have to throw your dinner mints and gum in the trash if you want gains.

But according to research, mint may be one of those foods that kill testosterone.

A study found that high levels of spearmint has an adverse effect on fertility in adult male rats, not to mention, there are a few studies on rats that found the same effects (21, 22, 23).

Another study found involving 42 women with PCOS found that the group who drank spearmint tea over 30 days experienced a significant reduction in testosterone (24).

Theres isnt much research in men but these are interesting studies.

Licorice root is used in food products such as candies, tobacco products, and other food items. Today its used to treat a variety of ailments such as digestive issues, menopause, and viral infections.

One study showed a 26% decrease in mean testosterone in 25 healthy adult men in just a week after consuming 7g/d. And there was a similar result in a study of women who took 3.5g/d and saw a decrease of 32% following a menstrual cycle (25, 26).

Related: 7 Ways To Boost Your Testosterone Naturally also check our top pick for Best Testosterone Boosters.

We hope our list of 8 foods that kill testosterone gave you some insight into nutritional choices that may be worth limiting. There are some interesting studies that have found negative associations between some foods and lower testosterone levels. But well admit that for many of these foods, there needs to be more research to come to any definitive conclusions.

Our best piece of advice is to use your best judgment, keep track of your nutritional choices, and if youre concerned about your testosterone levels, have them checked.

1. Mederos, Michael A.; Bernie, Aaron M.; Scovell, Jason M.; Ramasamy, Ranjith (2015).Can Serum Testosterone Be Used as a Marker of Overall Health?.Reviews in Urology.17 (4): 226230.ISSN1523-6161.PMC4735669.PMID26839520.

2. Hu, Tzu-Yu; Chen, Yi Chun; Lin, Pei; Shih, Chun-Kuang; Bai, Chyi-Huey; Yuan, Kuo-Ching; Lee, Shin-Yng; Chang, Jung-Su (2018-11-16).Testosterone-Associated Dietary Pattern Predicts Low Testosterone Levels and Hypogonadism.Nutrients.10(11).doi:10.3390/nu10111786.ISSN2072-6643.PMC6266690.PMID30453566.

3. Copetti, Cristiane; Franco, Fernanda Wouters; Machado, Eduarda da Rosa; Soquetta, Marcela Bromberger; Quatrin, Andria; Ramos, Vitor de Miranda; Moreira, Jos Cludio Fonseca; Emanuelli, Tatiana; Sautter, Cludia Kaehler; Penna, Neidi Garcia (2018-03-01).Acute Consumption of Bordo Grape Juice and Wine Improves Serum Antioxidant Status in Healthy Individuals and Inhibits Reactive Oxygen Species Production in HumanNeuron-Like Cells.Journal of Nutrition and Metabolism.2018.doi:10.1155/2018/4384012.ISSN2090-0724.PMC5852837.PMID29686894

4. Pavlidou, Eleni; Mantzorou, Maria; Fasoulas, Aristeidis; Tryfonos, Christina; Petridis, Dimitris; Giaginis, Constantinos (2018-08-08).Wine: An Aspiring Agent in Promoting Longevity and Preventing Chronic Diseases.Diseases.6(3).doi:10.3390/diseases6030073.ISSN2079-9721.PMC6165230.PMID30096779

5.Appendix 9. Alcohol 2015-2020 Dietary Guidelines | health.gov.health.gov. Retrieved2020-10-01.

6. Frias, J.; Torres, J. M.; Miranda, M. T.; Ruiz, E.; Ortega, E. (2002-03).Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adults of both sexes.Alcohol and Alcoholism (Oxford, Oxfordshire).37 (2): 169173. doi:10.1093/alcalc/37.2.169.ISSN0735-0414.PMID11912073.

7. German, J. B.; Walzem, R. L. (2000).The health benefits of wine.Annual Review of Nutrition.20: 561593. doi:10.1146/annurev.nutr.20.1.561.ISSN0199-9885.PMID10940346.

8. Jargin, Sergei V. (2014-12-15).Soy and phytoestrogens: possible side effects.GMS German Medical Science.12.doi:10.3205/000203.ISSN1612-3174.PMC4270274.PMID25587246.

9. Dillingham, Barbara L.; McVeigh, Brianne L.; Lampe, Johanna W.; Duncan, Alison M. (2005-03).Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men.The Journal of Nutrition.135 (3): 584591.doi:10.1093/jn/135.3.584.ISSN0022-3166.PMID15735098.

10. Hamilton-Reeves, Jill M.; Vazquez, Gabriela; Duval, Sue J.; Phipps, William R.; Kurzer, Mindy S.; Messina, Mark J. (2010-08).Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis.Fertility and Sterility.94 (3): 9971007.doi:10.1016/j.fertnstert.2009.04.038.ISSN1556-5653.PMID19524224.

11. Publishing, Harvard Health.The truth about fats: the good, the bad, and the in-between.Harvard Health.Retrieved2020-10-01.

12. Nagata, C.; Takatsuka, N.; Kawakami, N.; Shimizu, H. (2000).Relationships between types of fat consumed and serum estrogen and androgen concentrations in Japanese men.Nutrition and Cancer.38 (2): 163167. doi:10.1207/S15327914NC382_4.ISSN0163-5581.PMID11525593.

13. Volek, J. S.; Kraemer, W. J.; Bush, J. A.; Incledon, T.; Boetes, M. (1997-01).Testosterone and cortisol in relationship to dietary nutrients and resistance exercise.Journal of Applied Physiology (Bethesda, Md.: 1985).82 (1): 4954.doi:10.1152/jappl.1997.82.1.49.ISSN8750-7587.PMID9029197.

14. Selby, C. (1990-11).Sex hormone binding globulin: origin, function and clinical significance.Annalsof Clinical Biochemistry. 27 ( Pt 6): 532541.doi:10.1177/000456329002700603.ISSN0004-5632.PMID2080856.

15. Selby, C. (1990-11).Sex hormone binding globulin: origin, function and clinical significance.Annalsof Clinical Biochemistry. 27 ( Pt 6): 532541.doi:10.1177/000456329002700603.ISSN0004-5632.PMID2080856.

16. Mason, Julie K.; Thompson, Lilian U. (2014-06).Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer?.Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme.39 (6): 663678.doi:10.1139/apnm-2013-0420.ISSN1715-5320.PMID24869971.

17. Demark-Wahnefried, Wendy; Polascik, Thomas J.; George, Stephen L.; Switzer, Boyd R.; Madden, John F.; Ruffin, Mack T.; Snyder, Denise C.; Owzar, Kouros; Hars, Vera; Albala, David M.; Walther, Philip J. (2008-12). Flaxseed Supplementation (not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.17 (12): 35773587.doi:10.1158/1055-9965.EPI-08-0008.ISSN1055-9965.PMC2703189.PMID19064574.

18. Adlercreutz, H.; Hckerstedt, K.; Bannwart, C.; Bloigu, S.; Hmlinen, E.; Fotsis, T.; Ollus, A. (1987).Effectof dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG).Journal of Steroid Biochemistry.27(46): 11351144. doi:10.1016/0022-4731(87)90200-7.ISSN0022-4731.PMID2826899.

19. Nadjarzadeh, Azadeh; Dehghani Firouzabadi, Razieh; Vaziri, Niloofar; Daneshbodi, Hoorieh; Lotfi, Mohammad Hassan; Mozaffari-Khosravi, Hassan (2013-8).The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial.Iranian Journal of Reproductive Medicine.11 (8): 665672.ISSN1680-6433.PMC3941370.PMID24639805.

20. Demark-Wahnefried, W.; Price, D. T.; Polascik, T. J.; Robertson, C. N.; Anderson, E. E.; Paulson, D. F.; Walther, P. J.; Gannon, M.; Vollmer, R. T. (2001-07).Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.Urology.58 (1): 4752.doi:10.1016/s0090-4295(01)01014-7.ISSN1527-9995.

21. Demark-Wahnefried, W.; Price, D. T.; Polascik, T. J.; Robertson, C. N.; Anderson, E. E.; Paulson, D. F.; Walther, P. J.; Gannon, M.; Vollmer, R. T. (2001-07).Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.Urology.58 (1): 4752.doi:10.1016/s0090-4295(01)01014-7.ISSN1527-9995.PMID11445478.

22. Sampaio, Francisco J. B. (2004-07).Effects of peppermint teas on plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels and testicular tissue in rats.International Braz J Urol: Official Journal of the Brazilian Society of Urology.30 (4): 350351.ISSN1677-5538.PMID15679984.

23. Sadeghi Ataabadi, Mahmood; Alaee, Sanaz; Bagheri, Mohammad Jafar; Bahmanpoor, Soghra (2017-12).Roleof Essential Oil of Mentha Spicata (Spearmint) in Addressing Reverse Hormonal and Folliculogenesis Disturbances in a Polycystic Ovarian Syndrome in a Rat Model.Advanced Pharmaceutical Bulletin.7 (4): 651654. doi:10.15171/apb.2017.078.ISSN2228-5881.PMC5788221.PMID29399556.

24. Grant, Paul (2010-02).Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial.Phytotherapy research: PTR.24 (2): 186188. doi:10.1002/ptr.2900.ISSN1099-1573.PMID19585478.

25. Armanini, D.; Bonanni, G.; Mattarello, M. J.; Fiore, C.; Sartorato, P.; Palermo, M. (2003-09).Licoriceconsumption and serum testosterone in healthy man.Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association.111 (6): 341343. doi:10.1055/s-2003-42724.ISSN0947-7349.PMID14520600.

26. Armanini, Decio; Mattarello, Mee Jung; Fiore, Cristina; Bonanni, Guglielmo; Scaroni, Carla; Sartorato, Paola; Palermo, Mario (2004-10).Licorice reduces serum testosterone in healthy women.Steroids.69 (1112): 763766. doi:10.1016/j.steroids.2004.09.005.ISSN0039-128X.PMID15579328.

Written by Matthew Magnante.Medically reviewed by: Dr. Malik, DPT.

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

Follow this link:
8 Foods That Kill Testosterone (Potentially) Fitness Volt - FitnessVolt.com

MarketsandResearch.biz has carefully uploaded a smart research report titled Global Testosterone Cypionate Injection Market 2020 by Manufacturers, Type and Application, Forecast to 2025 to its immense online database. The report shares informative data figures and important insights associated with the market components. The report answers business challenges all the more rapidly and also saves a lot of time. The research presents an overview of the relevant market including analysis, latest market trends, and developments. The study covers an assortment of market factors, such as, drivers, opportunities, and restrictions. Authors estimate factors such as market size, market share, market segmentation, significant growth drivers, market competition, expected business up-downs, and key companies operating in the global Testosterone Cypionate Injection market. The past and current global market conditions are explained.

The report is further divided by company, by country, and by application/types. Then has mentioned production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global market. It also presents the potential industry supply, market demand, market value, market competition, key market players, and the industry estimate from 2020-2025. The segments are studied based on their market share, revenue, regional growth, cost, and revenue analysis. The study includes data about the regional business scope of the market and the status of various market players in the global Testosterone Cypionate Injection market.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/82300

In the report, the competitive landscape and the parallel detailed analysis of all the key market players are mentioned. Some of the major market players that are included in the report include: Cipla, Paddock Laboratories, Pfizer, Hikma, Perrigo, Perrigo, Genesis Pharmaceuticals, Sun Pharma, Meditech Pharmaceutical

By the product type, the market is primarily split into: 100mg/ml, 200mg/ml

By the end-users/application, this report covers the following segments: Hospital, Clinics, Recovery Center

The report forecasts the market size of segments with respect to countries in North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), MENA (Saudi Arabia, UAE, Turkey and South Africa)

What Are The Financial Metrics For The Industry?

This report encompasses many financial metrics for the global Testosterone Cypionate Injection industry including profitability, market value- chain, and key trends affecting the companys growth, revenue, return on sales. The report also provides company rank against its competitors with respect to revenue, profit comparison, cost competitiveness, and market capitalization. It includes the industry studies sales growth, and productivity (revenue). The report enhances its focus on the estimates of 2020-2025 market development trends.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/82300/global-testosterone-cypionate-injection-market-2020-by-manufacturers-type-and-application-forecast-to-2025

What The Market Research Report Basically Consists Of?

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

You May Check Also Other Reports

Global Laboratory Evaporators Market 2020 Latest Innovations, Key Indicators and Future Development Status Recorded during 2020 to 2025

Global Polycarbonate Sheet Market 2020 Industry Statistics, Emerging Opportunities, Revenue and Volume Analysis by 2025

Global Medication Adherence Packaging Systems Market 2020 Research Report Segment Outlook, Growth Potentials and Analysis of COVID-19 Worldwide Outbreak

Global Nickel Brazed Plate Heat Exchangers Market 2020 Key Drivers, Future Estimations, Consumption Volume, Key Players and Regional Analysis to 2025

Global Ammonium Sulfate Market 2020 Scope of Current and Future Industry, SWOT Analysis and Investment Feasibility 2025

Read the original here:
Global Testosterone Cypionate Injection Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - The Daily Chronicle

When a man receives a diagnosis of prostate cancer, Dr. Charles Ryan has two immediate questions: Has it spread outside of the prostate and, if so, is it resistant to the hormonal therapy typically used to treat the disease?

When we talk about a patient with a life-threatening form of prostate cancer, thoseare typically patients who have both of those phenomena, said Ryan, director of the Division of Hematology, Oncology and Transplantation at the Masonic Cancer Center of the University of Minnesota in Minneapolis. The cancer spreads to the bone, and standard hormonal therapy stops being effective, so the cancer begins to grow despite the lowering of testosterone.

While those cancers, known as castration-resistant or hormone-resistant, represent the most advanced stage of the disease, the good news is that there are numerous ways to treat such cases, Ryan told CURE in an interview. In fact, he said, the number of treatments for prostate cancer has really exploded in the last four or five years, and its actually going to get even bigger in the next few.

Ryan: We can divide them into three or four categories. With hormonal therapy, the standard of care would be some form of ablation of the level of testosterone in the body (because testosterone fuels the cancer). We typically do this with injections that lower the level of testosterone by about 90%. The most commonly used drugs would be leuprolide (Lupron Depot), degarelix (Firmagon) and goserelin (Zoladex).

On top of that, we have targeted hormonal therapies that block the effect of testosterone even when the first line of therapies has failed. And thats where we have drugs like enzalutamide (Xtandi), abiraterone (Zytiga), apalutamide (Erleada) and darolutamide (Nubeqa).

Compared with some other cancers, we use relatively little chemotherapy, but we do have some very effective chemotherapies. Docetaxel can be used in advanced hormone-resistant disease or as an initial therapy for metastatic disease. And we have a drug called cabazitaxel, which is similar.

The new class of drugs that were using now is the PARP (poly-ADP ribose polymerase) inhibitors, which target the mechanism of DNA repair (making it harder for cancer cells to repair themselves when damaged; these are used in patients whose cancers are already deficient in this ability due to gene mutations). In addition, we have a cellular therapy called sipuleucel-T, which is used in castration-resistant, metastatic disease. Finally, we have a radioisotope called radium-223, which is used in disease that has spread to the bone, causing bone pain.

Treatment adherence has to do with whether the prescribed medication actually gets into the patient. Adherence for injected drugs is, of course, high; if a patient shows up and has the drug injected, adherence is almost 100%. But with oral drugs, we can lose adherence for a number of reasons. One is that a patient could take a bottle of pills home, put it in his medicine cabinet and never take it. Or, it could be that a patient starts to take a medication and because he doesnt feel so good, he stops taking it. We would want to hear about that, why he doesnt feel well and whether we could reduce the dose or give him a treatment break. As oncologists, thats our job.

But the reality is that all the research in the world that leads to the development of a new therapy isnt effective if we dont get it into the patient. So, its sort of a dialogue between the doctor and the patient about what can or cannot be administered and why. It may not be just one factor.

Unfortunately, a problem in this country is that patients sometimes bear a lot of the cost of their medication, so not being able to pay would be one (reason) for a patient not adhering to the treatment regimen. And that is something that I, as a doctor, would want to hear about, because we can think about patient assistance programs if they exist in your area, or we can think about ways we can reduce the dose to allow us to effectively deliver the drug, but perhaps on a slightly more cost-effective schedule.

The major driver of quality of life in advanced prostate cancer is the efficacy of the therapy, and this has been shown, for example, with chemotherapy. Many men might think, Well, chemotherapy is going to be associated with a very poor quality of life. But that didnt bear out in a study that was done many years ago, in which patients (newly diagnosed) with metastatic disease were treated with standard hormonal therapy with or without chemotherapy.

The patients who were on the chemotherapy had a slightly lower quality of life after about three months of treatment, but after 12 months of starting treatment, the patients who had received the chemotherapy had a better quality of life. And that was because 12 months after starting the treatment, the patients had already been done with the treatment for six months. They were less likely to have their cancer worsening, and better cancer control leads to better quality of life.

I would put clinical trials into one of two categories. The first would be optimization studies using therapies that exist, but maybe were testing them in an earlier disease population, or looking for a better outcome by giving it to a patient with a lower volume of disease.

For example, there are studies of enzalutamide and abiraterone, commonly used drugs that, when first approved, were given to patients who had received all (available) prior therapies and chemotherapy. But then we showed that we could give them to patients with castration-resistant prostate cancer who did not have chemotherapy, and then to patients (who were) newly diagnosed, and the outcomes were better than giving standard hormonal therapy alone.

Now, studies are looking at patients who do not have metastatic disease. This is where were going with prostate cancer therapies: Optimizing their use, moving them earlier in the disease spectrum and maybe changing doses.

The next type of clinical trial would be (one that uses) new therapies and new approaches. One would be the PARP inhibitors, which are relatively new. The two that are approved currently are called Lynparza (olaparib) and Rubraca (rucaparib).

The second category thats really exciting is PSMA (prostate-specific membrane antigen) targeted therapies, and we have one thats looking really interesting. Its a molecule that targets PSMA (a protein in prostate cancer cells that fuels the disease), which arises from a very common mutation of a gene called PTEN. On one end, the treatment binds the PSMA, and on the other end, it has a sort of molecular basket.

In this basket, you can put a molecule: In this case, its the radioisotope lutetium-177. The targeted treatment sort of hand delivers the radiation therapy to the prostate cancer cell. And that looks really interesting and could get FDA (Food and Drug Administration) approval in the next few months or year.

Theres another less-known, genetic-based therapy being studied, a drug that targets a molecule called AKT (generated by a fairly uncommon) mutation. If that mutation is there, then this AKT is activated and stimulating the cancer, and the drug blocks it. We might hear data on that in the coming year, and it could become available, most likely, in the advanced castration-resistant metastatic setting.

We started maybe 20 years ago thinking about this idea of personalized medicine and targeted therapies, and were kind of there. Were not quite there totally, because were not at the point where every patient has some unique profile that leads to a special cocktail of treatment. I think thats still a little bit far off, but we are seeing the beginning of this process.

I would first recommend that patients go to the website of ZERO The End of Prostate Cancer.

ZERO is not only an informative website, its also an advocacy organization. ZERO also has an annual meeting that patients can attend. Ive spoken at it the last couple of years, and I have a number of colleagues who have, and theres a lot of information there.

I would also recommend looking at the National Cancer Institutes website. They have a thing called PDQ, patient data query, which is a very dry presentation of patient outcome data but can be helpful for making decisions.

And then, finally, the Prostate Cancer Foundation, which is a group that Ive worked with. They have patient materials that one can order, such as a cookbook for patients with prostate cancer and other things that can help them address lifestyle issues in a way that might be helpful for their long-term health.

Go here to see the original:
Treatments for Men Whose Prostate Cancer Has Spread and Become Resistant to Hormonal Therapy are Growing - Curetoday.com

The Swiss Federal Supreme Court recently dismissed an appeal by South African Caster Semenya, the womens 800m triple world champion and double Olympic gold winner, against a 2018 World Athletics regulation which ruled that athletes with hyperandrogenism needed to take testosterone reducing drugs to compete in womens track events between 400 and 1500m. The verdict could effectively bar Semenya from defending her title at the Tokyo Olympics, should she continue to refuse taking the drug. Anthropologist and bioethicist Katrina Karkazis, a senior research fellow with the Global Health Justice Partnership at Yale University, who served as expert witness in Indias Dutee Chands landmark legal battle against World Athletics over her ban over hyperandrogenism in 2015, spoke to Siddharth Saxena on the subject:

Did the Swiss courts outcome surprise you?

The Swiss Supreme Court had a very limited scope of review, which was to determine whether the regulations violate Swiss public policy. In that sense, the ruling was not surprising. What was extraordinary was, in ruling from such a narrow basis, that important findings of fact remain contested was obscured. What these cases underscore is that women athletes face significant barriers to seeking redress for violations of their human rights because these mechanisms fail to account for violations of those rights. That also holds for Dutee Chands case, because though her case was successful, it was not owing to recognition of harm.

World Athletics said the rule is to ensure a level playing field for women.

The idea of a level playing field is illusory given the myriad factors that impact athleticism. Moreover, testosterones effect on athleticism isnt straightforward. Many studies across a range of sports show mixed and unfixed relationships between performance and T [testosterone]. And while T does affect parameters related to athleticism, the relationships dont translate into better sports performance in a clear-cut way. Framing fairness this bluntly ignores that science, which has macro-level consequences, but it also affects real-life women in that it advantages women from the Global North while harming women from the Global South.

Will this ruling trigger interventions that could be potentially harmful?

The women who have been targeted under these regulations have spoken powerfully about the real and potential harms they have experienced. This ruling has authorised those harms. Policy makers, arbitrators and others have presented a scenario of opposing rights between women with higher testosterone and women with lower testosterone. This not only pits women against one another, but it inverts the operations of power and harm the least advantaged are positioned as unfairly advantaged, and any interventions that would alter their T levels are framed as necessary to fairness or even beneficial to them personally. The discrimination is not just against women. It is against womens narratives about harm.

Will this kind of ruling add to the way people connect T and athleticism?

We wouldnt have regulations like these if T was not gendered. The idea that testosterone is a male sex hormone responsible for all things manly and masculine and thus problematic in women is an idea that wont die. But this 100-year-old fallacy instigates regulations like these and enables them by making them sound logical, rational, and scientific. Some of the most pernicious misconceptions are that higher testosterone is a problem in women, it is the most important factor in athleticism, it accounts for the differences between mens and womens performances, and that there is a simple relationship between how much testosterone someone has and their athletic performance.

You have said that the hallmarks of T have been yoked exclusively to men (is) less a function of science than of ideology.

Even before testosterone was isolated, researchers worked from the assumption that so-called sex hormones would be exclusive to one sex or the other, and that their physiological roles would be restricted to sexual development and functions. Testosterone and estrogen were assumed to be antagonistic. By the 1930s, however, researchers knew that the effects of these hormones went well beyond sex. Historians and biologists have chronicled decades of experiments that cemented the identities of T as the male sex hormone and estrogen as the female sex hormone even as scientists struggled to integrate observations that didnt easily fit this paradigm. This concept has overwhelmingly shaped how scientific information about T is gathered and interpreted, and blocks recognition and acceptance of scientific evidence that does not fit the model, which is why the paradigm persists to this day.

What about testosterones relationship with women?

In the book, Testosterone: An Unauthorized Biography, we show how emerging work has demonstrated that T also plays a crucial role in female reproduction. Researchers and biomedical educators have been slow to acknowledge this relationship, which we believe is due to the way it challenges the sex hormone concept.

DISCLAIMER : Views expressed above are the author's own.

Read this article:
That testosterone is a male sex hormone and thus problematic in women is an idea that wont die - The Times of India Blog

A comprehensive report titled Global Testosterone Replacement Therapy Market was recently added by Reports and Data provides radical insights into the operations of the Testosterone Replacement Therapy industry to provide guidance to the established companies as well as new entrants. The report put a special emphasis on the leading players of the market along with a detailed analysis of the product portfolios, production capacities, and business expansion strategies.

The report provides extensive coverage of the impact of the COVID-19 pandemic on the market with a detailed analysis of changing market dynamics and demands and trends patterns. The pandemic has disrupted the flow of the market and has changed the economic scenario on a global scale. The report covers the current and future impact of the pandemic on the key segments and overall growth of the market. Additionally, according to the report, the market is expected to recover at a significant rate in a post-COVID-19 scenario.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/229

The report on Global Testosterone Replacement Therapy Market is an extensive study that provides crucial insights into the market with respect to recent developments, product advancements, business expansions, and other key aspects of the market. Moreover, it covers a comprehensive analysis of the drivers, restraints, market opportunities and growth prospects, limitations, and threats faced by the companies in the market. The report covers a detailed analysis of the key players operating in the market with their business and market strategies.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

Additionally, the report analyzes several factors, such as productivity and manufacturing, product types, and applications in the key geographical regions of the world. The various global regions investigated in this report are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. To gain a better understanding of the scope of the industry, competitive landscape and different progressive aspects are studied extensively in the report.

Furthermore, the report includes complete coverage of recent R&D advancements, product launches, mergers and acquisitions, online and offline activities, and other strategic initiatives undertaken by the key companies. The statistical data is further organized into tables, charts, graphs, diagrams, and infographics.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/229

Market Segmentation by Type:

Segmentation of the Market by Application:

Key offerings of the report:

To read more about the report, visit @ https://www.reportsanddata.com/report-detail/global-testosterone-replacement-therapy-market-by-manufacturers-countries-type-and-application-forecast-to-2022

Thank you for reading our report. To know more about customization options, please get in touch with us and our team will ensure the report is customized to meet your requirements.

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.

Contact Us:

John Watson

Head of Business Development

Reports and Data|Web: http://www.reportsanddata.com

Direct Line:+1-212-710-1370

E-mail: [emailprotected]

View post:
Testosterone Replacement Therapy Market 2020: Size, Cost Structures, Growth rate and Industry Analysis to 2027 - The Market Records

Sundance vet Laura Gabbert (No Impact Man, Sunset Story) is no stranger to the foodie world, having directed 2015s City of Gold, which follows the Pulitzer Prize-winning food writer Jonathan Gold on his culinary excursions throughout LA. Now, with Ottolenghi and the Cakes of Versailles, Gabbert turns her lens to the other coast and across the pond, globetrotting through time and space with seven-time NY Times bestselling cookbook author and renowned restauranteur Yotam Ottolenghi. Though the Israeli Jew (whose business partner is a Jerusalem-born Muslim) is based in London, hes invited by the Met to curate an edible, cake-centric exhibition inspired by the decadence of Versailles. So of course Ottolenghi does what any modern-day man of the world would do takes to Instagram to assemble a culturally diverse team of the most cutting edge pastry chefs one can find.

The troupe ends up including high-profile pastry artists like James Beard Award-winners Dominique Ansel, inventor of the Cronut, and Ghaya F. Oliveira, the Tunisia-born Executive Pastry Chef at NYCs Michelin star restaurant Daniel. But theres also Londons jelly wizards Sam Bompas and Harry Parr (Bompas & Parr), Singaporean Janice Wong, who specializes in interactive edible art (and once built a chocolate wall an installation screaming to be staged on the US-Mexico border if ever there was one), and the relatively unknown (though not for long) Dinara Kasko, a Ukrainian chef trained in architecture who uses 3D-modeling technology to craft building-inspired cakes. In other words, Ottolenghi and the Cakes of Versailles is both a study in artistic creation and a feast for the eyes.

Prior to the docs September 25 release through IFC Films Filmmaker reached out to Gabbert to learn all about the project, from finding fast foodie financing to filming the banquet of Versailles.

Filmmaker: So how did this doc originate? It seems almost an extension of your prior work, most notablyCity of Gold.

Gabbert: This project was brought to me by producer Steve Robilliard and Original Productions. They were already in talks with Yotam abouthis collaboration with the Met. I came onboard as director a few months before it was shot.

I was excited to work with Yotam, and intrigued by the challenge of making a film about the rise and fall of Versailles through patisserie. I suppose that in this way the film is an extension of City of Gold. Food is such a relatable point of departure to dive more deeply into cultural, historical, and political issues.

Filmmaker: Though the film is centered squarely around Ottolenghi, it seems like all of the other characters could have just as easily been the stars of their own docs. So did you have to leave a lot of footage on the cutting room floor, or did you purposely avoid delving too much into the other artists stories?

Gabbert: I agree. Yotam selected five fascinating pastry chefs. Because the film was shot in 12 days, we simply didnt have the time or budget to travel to Ukraine, for example, to delve into Dinara Kaskos life.

The focus had to remain on the preparation of the event itself, and Yotams process in researching and learning about Versailles and the history of patisserie. There were a lot of dots to connect: the Met exhibition Visitors to Versailles ; the history of Versailles; the history of patisserie; the five pastry chefs; and then of course, Yotam himself. I didnt want Yotam to just be our guide through the process of the event. I hope the brief biographic forays about Yotam give the collaboration an important layer of context.

So much great stuff was cut. Theres a scene we shot with Yotam on a train ride from Paris to Versailles where he talks about the food of his childhood in Israel, and the difference in the appropriation of Italian cuisine by the French. That was a hard scene to cut.

Filmmaker: I found the final unveiling of the feast of Versailles towards the end unexpectedly moving. Can you talk a bit about the creative decisions behind that sequence, especially the music and the use of Steadicam?

Gabbert: Ryan Rumerys beautiful score was key to editing that sequence. He and I discussed the emotion we wanted to capture, and that it also had to support a lot of VO from Yotam. Theres the emotion of each chefs accomplishment and later in the sequence the music also had to support the story of the fall of Versailles. When we tackled the first cut of it Ryan had already delivered pretty fleshed-out musical sketches. His interpretation of the sequence completely informed the editing of the last 10 minutes or so of the film.

Its such a luxury to be able to use a Steadicam on a documentary. We knew it was key to capturing the pastry chefs presentation tables and desserts, and the excitement of the event. Our DP Judy Phu and I wanted that sequence to have a lot of movement and emotion in it so that you felt that you were there, walking through the Petrie Gallery. We also had shooters stationed at each chefs table so we could capture more intimate moments between the chefs and the guests.

Filmmaker: You work with a majority female team, and Ottolenghi, a gay Jew from Jerusalem with a Muslim business partner, seems incredibly dedicated to inclusivity, inviting culinary artists from a variety of cultures, with half of the chosen being women. You also include a telling scene of mansplaining involving the Ukrainian architect chef Dinara Kasko. All of which made me wonder how important it was for you to highlight the everyday misogyny and cultural appropriation Ottolenghi even points out that the French appropriated pastry from the Italians in this rarified culinary world. (With elitism ironically exemplified, of course, by both the Met and Versailles.)

Gabbert: I think Yotam really set the tone for the film in his selection of the pastry chefs. I love that three out of the five chefs he selected were women. One of the reasons I wanted to work with Yotam is that he is a bit of an anomaly in the celebrity chef world. Hes cerebral, refined and kind. Theres no bravado.

One of the beats of Yotams story that I fought to get into the film is when he talks about starting out as a young chef in kitchens, and how he felt like an outsider in that testosterone-driven climate. He goes on to explain that when he had his own restaurants he wanted for the environment to be gentler and more respectful. I think part of what made this a fruitful collaboration was that there was an immediate simpatico between Yotam and the key creatives on my team (producer Steve Robilliard and DP Judy Phu).

The decision to include the Dinara Kasko scene (not that we could have planned it) just felt right in terms of the overall tone and message of the film especially in light of all the toxic masculinity stories in the food world that have surfaced in the last couple of years.

Filmmaker: On the one hand, Ottolenghi is a famous name in the culinary world and the topic sells. But on the other hand, theres been quite a glut of foodie docs in the past few years. So how difficult was it to ultimately get the financing?

Gabbert: The film was developed by Steve Robillard at Original Productions and co-financed by 50 Degrees Entertainment and Original Productions. The financing actually happened fairly quickly thanks to Mohamed AlRafi and Paula Manzanedo at 50 Degrees Entertainment.

View original post here:
An Outsider in that Testosterone-Driven Climate: Laura Gabbert on Her Food Doc, Ottolenghi and the Cakes of Versailles - Filmmaker Magazine

Welcome to the latest edition of the RPC Sports Ticker - providing fortnightly bite-size updates from around the sports industry.

Access the full Sports Ticker and subscribe here

In this edition, we take a look at the opening of Hong Kong's first esports stadium, Apple's new personalised workout subscription service and the recent House of Commons debate on misogyny in modern sport. We also consider the Federal Supreme Court of Switzerland's decision to uphold regulations restricting testosterone levels in female track athletes and Lewis Hamilton's venture into the new Extreme E racing series.

As always, if there are any areas youd like more information on (or if you have any questions or feedback), please let us know or get in touch with your usual RPC contact.

1. Hamilton raises Extreme impact of climate change through motorsports

Lewis Hamilton has pledged to enter a team to compete in the Extreme E racing series. Extreme E is an off-road racing series, scheduled to start in Dakar, Bangladesh in January 2021. Electric SUVs will race for 2 days in various remote locations, with the races to be streamed live on BBC Sport.

2. Apple takes further bite of wearable technology market

You might already have AppleCare, Apple News+, Apple Music, Apple TV+ (and more). Now, say hello to Apple Fitness+, Apple's latest subscription service for fitness and workout classes. Like many others, Fitness+ plays on competitive rivalry by letting you see how your performance compares to other users online.

3. Parliament debates misogyny in sport

Last week saw Alex Davies-Jones MP consider sexist, homophobic and misogynistic experiences in sport during a House of Commons Adjournment debate.

4. Swiss Supreme Court rejects Semenya's appeal

Two-time Olympic champion Caster Semenya will be unable to defend her 800m Olympic title next year after losing her appeal against the restriction of testosterone in female athletes.

5. Hong Kong opens its first esports stadium

In a city where space is at a premium, the Asia Motion Esports Association (AME) is opening Hong Kong's first esports stadium.

Extra time...

and finally, BDO has published its Annual Survey of Football Club Finance Directors for 2020 (available here). Following developments in football finance, across all leagues, all but two-fifths of the Premier League clubs expect to make losses before player trading in 2019/20. Player budgets are expected to be constrained with 60% of clubs intending to decrease their squad size and 74% intending to decrease their salary costs. Notably, no club is positively stating that it is increasing their transfer budget, though 30% of clubs expect to let several player contracts expire this season, and less than one in four clubs will be increasing their investment in their academy next season. Elsewhere, the report found that clubs are realising the need to capture digital media opportunities, both domestically and internationally, and the need to monetise their commercial and data brand.

See more here:
RPC Sports Ticker (25 September 2020) - esports, wearable tech and Semenya appeal - Lexology

The coronavirus pandemic has dominated the headlines and our daily lives for most of this year. Medical News Today have covered this fast-moving, complex story with live updates on the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask.

However, this has not stopped us from publishing hundreds of fascinating stories on a myriad of other topics.

This week, our Medical Myths series marked World Alzheimers Day by challenging 11 misconceptions people may have about dementia. We also reported on a long-term study that supports the use of testosterone therapy to reduce obesity in people who might otherwise undergo bariatric surgery.

As part of a series of articles on health issues in the 2020 presidential election, we published a story on how voting and wider participation in politics may bring mental health benefits. Look out for more articles on health and the election in the coming weeks.

We round off this weeks selection with a collection of healthful recipes for weight loss, an inspiring personal story from a sickle cell anemia survivor, and our pick of the best aromatherapy candles to relieve stress safely and fragrantly.

Below are 10 recent stories that people may have missed amid all the COVID-19 fervor.

The latest installment in our Medical Myths series tackles 11 myths about dementia. Tim Newman, MNTs Senior News Editor, wrote this article to mark World Alzheimers Day on September 21.

The feature answers several crucial questions: Are Alzheimers disease and dementia the same thing? Is dementia an inevitable part of the aging process? Does dementia only affect older adults? And do vitamins and supplements have any role to play in preventing it?

Learn more here.

Our most popular news article this week reported on an 11-year study into the effects of testosterone on men with obesity who had clinically low levels of the hormone.

The results were striking, with males who received testosterone losing an average of 23 kilograms (kg), equivalent to 20% of their body weight. Those who did not receive treatment gained an average of 6 kg.

Those receiving treatment were also free of major cardiovascular events and type 2 diabetes, while 28% of those who did not receive testosterone therapy had a heart attack, and 20% developed diabetes.

Learn more here.

In a recent Recovery Room, we featured Medical News Todays investigation into how health influences voting behavior. This week, we look at how voting and civic engagement may benefit mental health and overall well-being.

Both articles are part of Medical News Todays ongoing coverage in the weeks leading up to the presidential vote, including the latest Letter from the Editor on the role that health will play in the 2020 election.

Learn more here.

Our readers spent an average of nearly 6 minutes each reading this article on a new technique for preventing motion sickness. Its an unpleasant condition with symptoms that include nausea and vomiting, while people may also experience sweating, dizziness, hyperventilation, headaches, restlessness, and drowsiness.

Motion sickness can occur in cars, buses, trains, airplanes, boats, and theme park rides. It can also develop while using virtual reality headsets.

Now, a new study suggests that 14 days of simple, pen-and-paper visuospatial training may help reduce motion sickness, broadening transport options in people who would otherwise suffer from it.

Learn more here.

What role does social context play in influencing peoples ability to process language? This was the question researchers in Spain set out to investigate in a recent study, covered in MNT this week.

The research finds that our brains behave differently when we read alone compared with when we read in company. The presence of another may boost creativity, but there are other, more systematic tasks where reading alone may be beneficial.

Learn more here.

A recent study in mice adds to evidence suggesting that, aside from attacking pathogens, the immune system might influence mood and anxiety. One of the immune signaling molecules, or cytokines, that mediates these links is called interleukin-17a (IL-17a).

In the study, researchers at the University of Virginia School of Medicine in Charlottesville found that IL-17a causes anxiety-like behavior in mice. The team now plans to investigate whether too much or too little IL-17a could affect anxiety in people.

Learn more here.

Last month, MNT launched a collection of articles on the science of sleep that covered topics such as dreaming, sleep disorders, and how to get a good nights rest.

This week, we reported on a new study investigating how getting enough shut-eye helps people maintain emotional equilibrium and allows them to enjoy the good things in life.

When people experience something positive, such as getting a hug or spending time in nature, they typically feel happier that day. But we found that when a person sleeps less than their usual amount, they dont have as much of a boost in positive emotions from their positive events, says lead author Nancy Sin.

Learn more here.

As well as reporting on the latest medical and science news, and how health intersects with politics and inequality, MNTs editors also produce articles that help with the everyday practice of healthful living.

This new feature presents healthful eating tips and recipes for breakfast, lunch, and dinner to help people kickstart their weight loss journey. We also look at the basic principles of weight loss and how the microbiome plays an important role.

Learn more here.

Through my eyes is a regular MNT feature where we invite contributions from people who have had personal experience with a health condition. Recent articles have shared the stories of those who have survived COVID-19, encephalitis, and misdiagnosed endometriosis.

This week, our contributor is Vanetta Morrison. Vanetta was born with a chronic illness and given a short life expectancy. Now, she helps people live their best lives from the inside out, and this is her story.

Learn more here.

Mind, body, and nose MNT have every aspect of your health and mental well-being covered this week, with this assessment of aromatherapy candles.

Aromatherapy candles contain essential oils, some of which may relieve stress. We look at the potential benefits, safety, and risks of using these products in your home.

Learn more here.

We hope these provide a taste of the stories we cover at MNT. We will be back with a new selection next week.

We publish hundreds of news stories and features every month. Here are some upcoming articles that may pique our readers interest:

More:
The Recovery Room: News beyond the pandemic September 25 - Medical News Today

"The niche and established Testosterone Replacement Therapy Market 2020 Covering Prime Players, Regions, Countries, And Growth Trends Forecast To 2026 is studied in this research report. The Industry dynamics with Testosterone Replacement Therapy future-proofing business plans are analyzed to offer sustainable growth for our clients. The insights-driven data covering the Testosterone Replacement Therapy competition, product demand across different operating regions, countries, and a variety of applications are covered. Actionable insights offered by Reports Check will help achieve you in achieving exemplary growth with feasible investments. To strengthen the position in the global and domestic Testosterone Replacement Therapy Market revenue, size & share analysis, import-export details, production capacity, and utilization ratio is offered.

Testosterone Replacement Therapy Market is expected to reach XX.XX Mn USD by 2026 and it will capture lucrative opportunities with rising demand. The market dynamics, SWOT analysis, Porters Analysis, the risk assessment will create discerning growth and profit-driven strategies. Reports Checks analyst team is fine-tuned to answer all client queries and well as to deliver custom solutions based on their requirements.

Click Here To Receive FREE Sample Report Copy Or Send Any Custom Query/Requirements:https://www.reportscheck.com/shop/2021-2026-report-on-global-testosterone-replacement-therapy-market-by-player-region-type-application-and-sales-channel/#sample-request

Study Period: 2015-2026

Base Year: 2019

Estimated Year With COVID-19 Impact Analysis:2020

Forecast Period Duration:2020-2026

Historical Period Duration:2015-2018

Important and Top Product Types:

GelsInjectionsPatchesOther

By Various Applications:

HospitalsClinicsOthers

By Top Companies On Global, Regional And Country Level:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

By Geographical Testosterone Replacement Therapy Industry Presence:

The current Testosterone Replacement Therapy Market landscape, detailed insights, and market drivers with restraints and trends are studied in this report. The detailed market performance during the forecast period is presented in this report. The Y-o-Y growth and CAGR is presented in this report to support the readers in making appropriate business plans. The quantitative development opportunities and innovations in Testosterone Replacement Therapy Industry are presented.

Click Here To Check Detailed Report Table of Contents With List of Figures/ Tables and Receive FREE Sample Report:https://www.reportscheck.com/shop/2021-2026-report-on-global-testosterone-replacement-therapy-market-by-player-region-type-application-and-sales-channel/#table-of-contents

All details including Testosterone Replacement Therapy market investors, manufacturers, service providers, distributors, stakeholders are provided. This research study by Reports Check helps the industry experts, researchers, investors, and business aspirants. The macro and microeconomic factors with substantive Testosterone Replacement Therapy insights are analyzed in this study.

All the above queries are effectively addressed by the analyst team of Reportscheck.com. Also, custom reports are available based on the client's requirements. Analyst views and opinions about the Testosterone Replacement Therapy industry with qualitative and quantitative inputs will lead to sound business plans. The investment feasibility check, the latest innovations, developments, raw materials, and Testosterone Replacement Therapy consumer demand analysis is conducted. The competitive dashboard reflects the top companies' analysis, growth rate, revenue, market share, product portfolio, and the latest developments.

Development trends, competitive analysis, and growth dynamics are key aspects of this report

Past, present, and forecast Testosterone Replacement Therapy industry evaluation with complete performance monitoring of top players,.

Each product type and application regional and country-level bifurcation offer comprehensive and niche Testosterone Replacement Therapy analysis

The product portfolio, Testosterone Replacement Therapy company profiles, SWOT, and Porters Five Forces analysis offers quality inputs

Pre and Post pandemic situations, ways to overcome pandemic, Testosterone Replacement Therapy developments across different macro and micro-segments are analyzed

Market size, product pricing analysis, Testosterone Replacement Therapy cost structures, raw material, and downstream buyers analysis is conducted

In-depth primary and secondary techniques applied by Reports Check provide quality, reliability, thorough analysis, and competitive market intelligence

Forecast regional, country-level dynamics, expected growth rate, revenue generation, upcoming segments, and Testosterone Replacement Therapy vendors, R&D status is specified

Browse our recently released reports here:https://www.reportscheck.com/shop/2021-2026-report-on-global-testosterone-replacement-therapy-market-by-player-region-type-application-and-sales-channel/

Contact Us:

Olivia Martin

Marketing Manager

Email: [emailprotected]

Website:www.reportscheck.com

Read this article:
2020 Revenue Analysis Of Testosterone Replacement Therapy Market By Sales, Pricing Structure, Top Companies, Types, Demand, Production Forecast 2026 -...

In 2025, the market size of the Testosterone Booster Market is expected to touch million US$ xx million. The revenue registered in 2019 was US$ xx million, thus depicting a growth at a CAGR of xx% from 2019. While in China, the market size was valued at US$ xx million in the forecast base year, further projected to increase up to US$ xx million till the end of 2025, with a CAGR of xx% during forecast period.

In this report, 2019 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Testosterone Booster .

This report studies the global market size of Testosterone Booster , especially focusing on the key regions such as United States, European Union, China, and other geographical extents (Japan, Korea, India, and Southeast Asia).

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2797504&source=atm

This study presents the Testosterone Booster market production, revenue, market share, and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. The historical data breakdown for Testosterone Booster for 2014-2019 is provided in the report along with company projection for 2019 to 2025.

For top companies in United States, European Union, and China, this report investigates and analyzes the production, value, price, market share, and growth rate for the manufacturers, key data from 2019 to 2025.

Segment by Type, the Testosterone Booster market is segmented intoD Aspartic AcidVitamin D3Other

Segment by Application, the Testosterone Booster market is segmented intoTeenagersAdults

Regional and Country-level AnalysisThe Testosterone Booster market is analysed and market size information is provided by regions (countries).The key regions covered in the Testosterone Booster market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Testosterone Booster Market Share AnalysisTestosterone Booster market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Testosterone Booster business, the date to enter into the Testosterone Booster market, Testosterone Booster product introduction, recent developments, etc.The major vendors covered:TestofuelGNCTestoTEKPrime MaleTEK NaturalsTestoGenPrime MaleNugenixMonster TTestoRush

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2797504&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1 describes Testosterone Booster product/service scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2 profiles the top manufacturers of Testosterone Booster market, with price, sales, revenue and global market share of Testosterone Booster from 2014 2019.

Chapter 3 analyses the Testosterone Booster competitive situation, sales, revenue. The global Testosterone Booster market shares of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4 showcases the Testosterone Booster breakdown data at the regional level, to discuss the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8, and 9 emphasize the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11 explain the segments by sales under type and application, with market shares and growth rate under each category, from 2014 to 2019.

Chapter 12 depicts Testosterone Booster market forecasts by region, type, and application, with sales and revenue projections, from 2019 to 2025.

Chapter 13 and 14 describe Testosterone Booster sales channel, distributors, customers, research findings and conclusion, appendix, and other data sources.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2797504&licType=S&source=atm

For More Information Kindly Contact:

ResearchMoz

Mr. Rohit Bhisey,

90 State Street,

Albany NY,

United States 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

More:
Testosterone Booster Market Rapidly Increasing in Size Globally : Latest Report with Current Trends and Future Estimations and Opportunity Analysis -...

Page 41«..1020..40414243..5060..»

Home » Testosterone » Page 41